Deng GC - Search Results

1

Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.

Deng GC, Sun DC, Zhou Q, Lv Y, Yan H, Han QL, Dai GH. Deng GC, et al. BMC Genomics. 2021 Nov 3;22(1):791. doi: 10.1186/s12864-021-08097-w. BMC Genomics. 2021. PMID: 34732125 Free PMC article.

2

CA19-9 decrease and survival according to platelet level in patients with advanced pancreatic cancer.

Chen Y, Wang YR, Deng GC, Dai GH. Chen Y, et al. Among authors: deng gc. BMC Cancer. 2019 Aug 30;19(1):860. doi: 10.1186/s12885-019-6078-2. BMC Cancer. 2019. PMID: 31470818 Free PMC article.

3

A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer.

Cui H, Guan J, Deng G, Yuan J, Lou C, Zhang W, Zhou A, Zhang Y, Zhou J, Dai G. Cui H, et al. Med Sci Monit. 2020 Oct 26;26:e927654. doi: 10.12659/MSM.927654. Med Sci Monit. 2020. PMID: 33100319 Free PMC article. Clinical Trial.

4

Correlation Between Baseline Serum Tumor Markers and Clinical Characteristic Factors in Patients with Advanced Pancreatic Cancer.

Deng GC, Yan H, Guo ZP, Dai G. Deng GC, et al. Onco Targets Ther. 2020 Nov 2;13:11151-11163. doi: 10.2147/OTT.S269720. eCollection 2020. Onco Targets Ther. 2020. PMID: 33173307 Free PMC article.

5

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer.

Deng GC, Lv Y, Yan H, Sun DC, Qu TT, Pan YT, Han QL, Dai GH. Deng GC, et al. BMC Cancer. 2021 Nov 15;21(1):1227. doi: 10.1186/s12885-021-08943-w. BMC Cancer. 2021. PMID: 34781928 Free PMC article.

6

Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection.

Guan S, Chen Y, Han Q, Deng G, Wang Y, Shi Y, Dai G. Guan S, et al. Transl Cancer Res. 2019 Jun;8(3):811-820. doi: 10.21037/tcr.2019.04.24. Transl Cancer Res. 2019. PMID: 35116819 Free PMC article.

7

A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies.

Pan Y, Si H, Deng G, Chen S, Zhang N, Zhou Q, Wang Z, Dai G. Pan Y, et al. Front Oncol. 2022 Feb 18;11:798415. doi: 10.3389/fonc.2021.798415. eCollection 2021. Front Oncol. 2022. PMID: 35251952 Free PMC article.

8

Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score.

Pan Y, Si H, Jia R, Deng G, Yan H, Fan M, Gou M, Chen S, Zhang N, Shi Y, Qian N, Dai G. Pan Y, et al. J Oncol. 2022 Mar 17;2022:1427779. doi: 10.1155/2022/1427779. eCollection 2022. J Oncol. 2022. PMID: 35342416 Free PMC article.

9

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma.

Guan S, Deng G, Sun J, Han Q, Lv Y, Xue T, Ding L, Yang T, Qian N, Dai G. Guan S, et al. Front Oncol. 2022 Aug 23;12:926260. doi: 10.3389/fonc.2022.926260. eCollection 2022. Front Oncol. 2022. PMID: 36081557 Free PMC article.

10

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.

Zhou Q, Deng G, Wang Z, Dai G. Zhou Q, et al. Front Surg. 2023 Jan 6;9:1002075. doi: 10.3389/fsurg.2022.1002075. eCollection 2022. Front Surg. 2023. PMID: 36684178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters